Company profile: Cardurion Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of cardiovascular therapeutics and research services, developing a PDE9 inhibitor for HFrEF and HFpEF to enhance existing therapy; a CaMKII inhibitor for CPVT, heart failure, and atrial fibrillation; and conducting clinical trials, plus medicinal chemistry, computational molecular modeling, and genetic engineering support for cardiovascular research.
Products and services
- CaMKII Inhibitor: A clinical-stage drug targeting hyperactivated CaMKII, intended to treat CPVT, heart failure, and atrial fibrillation across cardiovascular disease indications
- Clinical Trials: Investigational research studies designed to evaluate the safety and efficacy of Cardurion's investigational medicines for cardiovascular diseases
- PDE9 Inhibitor: An adjunctive treatment under development for chronic heart failure (HFrEF and HFpEF), aiming to improve efficacy when added to existing medical therapies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cardurion Pharmaceuticals
CardiAQ Valve Technologies
HQ: United States
Website
- Description: Provider of innovative heart valve replacement solutions, initially focused on transcatheter mitral valve implantation (TMVI), a minimally invasive catheter-based procedure for replacing the heart's mitral valve.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CardiAQ Valve Technologies company profile →
Dezima Pharma
HQ: The Netherlands
Website
- Description: Provider of protein-based compounds for the treatment of cardiovascular disease related to dyslipidemia; founded in 2012 and based in Naarden, the Netherlands.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dezima Pharma company profile →
Conavi Medical
HQ: Canada
Website
- Description: Provider of image guidance technologies for minimally invasive cardiovascular procedures, including catheter-based ultrasound that generates 2-D and 3-D images of intracardiac and intravascular anatomy around the catheter tip, and the Novasight Hybrid System, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Conavi Medical company profile →
WR Medical
HQ: United States
Website
- Description: Provider of medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WR Medical company profile →
Bellerophon Therapeutics
HQ: United States
Website
- Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cardurion Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cardurion Pharmaceuticals
2.2 - Growth funds investing in similar companies to Cardurion Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cardurion Pharmaceuticals
4.2 - Public trading comparable groups for Cardurion Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →